Difference between revisions of "Part:BBa K3408011"
NJAU-Chappie (Talk | contribs) |
NJAU-Chappie (Talk | contribs) |
||
| (3 intermediate revisions by 3 users not shown) | |||
| Line 3: | Line 3: | ||
This composite part consists of promoter P<sub>liaG</sub> and P<sub>grac</sub>, <i>lacI</i> gene, <i>CⅠ</i> gene, <i>gfp</i> gene and some essential RBS and terminators. P<sub>liaG</sub> starts transcription process and its expression product is LacI, which is regulated by IPTG. | This composite part consists of promoter P<sub>liaG</sub> and P<sub>grac</sub>, <i>lacI</i> gene, <i>CⅠ</i> gene, <i>gfp</i> gene and some essential RBS and terminators. P<sub>liaG</sub> starts transcription process and its expression product is LacI, which is regulated by IPTG. | ||
| − | LacI is the transcriptional repressor protein, which could bind to the specific site of | + | LacI is the transcriptional repressor protein, which could bind to the specific site of P<sub>grac</sub> to inhibit its activity. IPTG can break out this inhibition by prior combination with LacI. |
When our engineered bacteria is exposed to medium which is rich in IPTG, engineered bacteria can intake IPTG to trigger the expression of CⅠ repressor protein. | When our engineered bacteria is exposed to medium which is rich in IPTG, engineered bacteria can intake IPTG to trigger the expression of CⅠ repressor protein. | ||
| Line 23: | Line 23: | ||
</html> | </html> | ||
| − | Fig.1. The expression vector of device P<sub>liaG</sub>- | + | Fig.1. The expression vector of device P<sub>liaG</sub>-lacI-P<sub>grac</sub>-CⅠ-P<sub>CⅠ</sub>-GFP |
1.2.Construction and screening of recombinant engineered bacteria | 1.2.Construction and screening of recombinant engineered bacteria | ||
| − | Using <i> | + | Using <i>Bacillus subtilis</i> WB800N as the expression host, the secretion expression vector pWB980-DB was transformed by electro-transformation. Inoculate them on LB solid medium coated with 10 μg/mL kanamycin, and incubate them overnight at 37 °C. Send transformants to biotechnology company for sequencing. |
1.3.Characterization experiment | 1.3.Characterization experiment | ||
| − | Take 2 bottles of 50 ml LB liquid medium with 10 μg/mL kanamycin, and inoculate the same amount of recombinant | + | Take 2 bottles of 50 ml LB liquid medium with 10 μg/mL kanamycin, and inoculate the same amount of recombinant engineered bacteria. |
① After culturing for 3 hours, the test group is cultured with 1 mM IPTG at 37 °C and 200 rpm for 2 hours while the IPTG is not added to control group. | ① After culturing for 3 hours, the test group is cultured with 1 mM IPTG at 37 °C and 200 rpm for 2 hours while the IPTG is not added to control group. | ||
| Line 42: | Line 42: | ||
2. Expected results | 2. Expected results | ||
| − | Fluorescence can be observed in the negative control group but not in the test group. | + | Fluorescence can be observed in the negative control group but not be observed in the test group. |
<html> | <html> | ||
Latest revision as of 03:27, 28 October 2020
PliaG-B0034-lacI-Pgrac-B0034-CⅠ-PCⅠ-GFP-B0015
This composite part consists of promoter PliaG and Pgrac, lacI gene, CⅠ gene, gfp gene and some essential RBS and terminators. PliaG starts transcription process and its expression product is LacI, which is regulated by IPTG. LacI is the transcriptional repressor protein, which could bind to the specific site of Pgrac to inhibit its activity. IPTG can break out this inhibition by prior combination with LacI.
When our engineered bacteria is exposed to medium which is rich in IPTG, engineered bacteria can intake IPTG to trigger the expression of CⅠ repressor protein. Therefore, PCⅠ is inhibited and GFP could not be expressed.
By checking the expression of GFP, we could verify the feasibility of IPTG induction system, thus guaranteeing the successful culture of our engineered Bacillus subtilis.
1. Experimental methods
1.1.Construction of the expression vector
The pWB980-DB is digested with enzyme EcoRI and PstI. The target fragment of the promoter, RBS, gene of phytase and terminator of this device are synthesized by the biotechnology company with 6×His tags added. Add EcoRI and PstI restriction sites to both ends of the target fragment respectively. Connect the target fragment to the plasmid vector to construct the expression vector PliaG-lacⅠ-Pgrac-CⅠ-PCⅠ-GFP.
Plasmid profile
Fig.1. The expression vector of device PliaG-lacI-Pgrac-CⅠ-PCⅠ-GFP
1.2.Construction and screening of recombinant engineered bacteria
Using Bacillus subtilis WB800N as the expression host, the secretion expression vector pWB980-DB was transformed by electro-transformation. Inoculate them on LB solid medium coated with 10 μg/mL kanamycin, and incubate them overnight at 37 °C. Send transformants to biotechnology company for sequencing.
1.3.Characterization experiment
Take 2 bottles of 50 ml LB liquid medium with 10 μg/mL kanamycin, and inoculate the same amount of recombinant engineered bacteria.
① After culturing for 3 hours, the test group is cultured with 1 mM IPTG at 37 °C and 200 rpm for 2 hours while the IPTG is not added to control group.
② Use the fluorescence microscope to observe the presence of fluorescence in the test group and the control group.
2. Expected results
Fluorescence can be observed in the negative control group but not be observed in the test group.
Fig.2. Expected results: different expressions of fluorescence between the control group and the test group.
These results are predicted because of the lack of experiment for the COVID-19.
Sequence and Features
- 10COMPATIBLE WITH RFC[10]
- 12COMPATIBLE WITH RFC[12]
- 21INCOMPATIBLE WITH RFC[21]Illegal BglII site found at 1294
- 23COMPATIBLE WITH RFC[23]
- 25COMPATIBLE WITH RFC[25]
- 1000INCOMPATIBLE WITH RFC[1000]Illegal BsaI.rc site found at 2155